List of insiders holdings for ARRAY BIOPHARMA INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 2017-02-14 12:37:18 | 4,986,186 0 | 4,986,186 | Form 13G |
| KOCH KEVIN President, CSO | 2013-08-02 18:22:16 | 786,917 142,286 | 929,203 | Form 4/A |
| CONWAY ROBERT CEO | 2011-10-04 17:05:18 | 633,386 80,000 | 713,386 | Form 4 |
| CARUTHERS MARVIN H Director | 2011-08-16 12:55:42 | 177,763 269,171 | 446,934 | Form 4 |
| Yates John CMO | 2007-05-16 19:41:12 | 400,000 0 | 400,000 | Form 4 |
| Oltmans Curtis Gale General Counsel | 2019-02-07 16:30:49 | 378,921 0 | 378,921 | Form 4 |
| Henahan Mary P. Chief Financial Officer | 2015-09-10 18:48:06 | 361,337 0 | 361,337 | Form 3 |
| PISCOPIO TONY VICE PRESIDENT, CHEMISTRY | 2005-08-08 17:39:35 | 80,000 0 | 80,000 | Form 4 |
| LEFKOFF KYLE Director | 2019-07-30 20:03:45 | 65,000 0 | 65,000 | Form 4 |
| MOORE JOHN R VP, General Counsel | 2017-04-06 20:30:59 | 40,102 0 | 40,102 | Form 4/A |
| Needle Michael N CMO | 2014-08-20 16:59:53 | 32,069 0 | 32,069 | Form 4 |
| CARRUTHERS MICHAEL CFO | 2014-08-20 17:01:01 | 25,655 0 | 25,655 | Form 4 |
| Ratcliffe Liam Director | 2013-10-25 16:05:31 | 25,000 0 | 25,000 | Form 4 |
| ZABRISKIE JOHN L Director | 2013-10-24 19:06:05 | 25,000 0 | 25,000 | Form 4 |
| BULLOCK FRANCIS J Director | 2011-10-27 17:56:46 | 20,000 0 | 20,000 | Form 4 |
| WILLIAMS DOUGLAS E Director | 2010-11-08 18:26:10 | 20,000 0 | 20,000 | Form 4 |
| SNITMAN DAVID COO and VP, Business Devel. | 2015-03-04 20:12:32 | 18,930 0 | 18,930 | Form 4 |
| Squarer Ron CEO | 2019-07-30 20:06:01 | 0 0 | 0 | Form 4 |
| Sharp Shalini Director | 2019-07-30 20:05:39 | 0 0 | 0 | Form 4 |
| Sandor Victor Chief Medical Officer | 2019-07-30 20:05:17 | 0 0 | 0 | Form 4 |
| Saccomano Nicholas A CSO | 2019-07-30 20:04:52 | 0 0 | 0 | Form 4 |
| Robbins Andrew R COO | 2019-07-30 20:04:27 | 0 0 | 0 | Form 4 |
| VAN LUNSEN GIL J Director | 2019-07-30 20:06:22 | 0 0 | 0 | Form 4 |
| Orwin John A Director | 2019-07-30 20:04:07 | 0 0 | 0 | Form 4 |
| Haddock Jason CFO | 2019-07-30 20:03:24 | 0 0 | 0 | Form 4 |
| Fyfe Gwen A. Director | 2019-07-30 20:03:02 | 0 0 | 0 | Form 4 |
| COX CARRIE SMITH Director | 2019-07-30 20:02:39 | 0 0 | 0 | Form 4 |
| BAUM CHARLES M Director | 2019-07-30 20:02:10 | 0 0 | 0 | Form 4 |
| Redmile Group LLC Green Jeremy 10% Owner | 2020-02-14 16:25:59 | 0 0 | 0 | Form 13G |
| Horin David J Interim CFO | 2015-02-09 15:47:09 | 0 0 | 0 | Form 3 |